Ledger.Open graph →
SEC Form D · filed April 18, 2024

Flagship Biosciences, Inc

Offering
$6.4M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BROOMFIELD, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

William Snider · Broomfield, CODirectorTom H. Turi · Broomfield, COExec · DirectorHerb H. Hooper · Broomfield, CODirectorPaul Kirchgraber · Broomfield, CODirectorTrevor Johnson · Broomfield, COExec · DirectorPaul Kirchgraber · Broomfield, CODirectorJ. R. Calliham · Myrtle Beach, SCExec · DirectorJohn C. Comer · Charleston, SCExec · DirectorWilliam R. Ragans · Bothell, WADirectorWilliam Snider · Broomfield, CODirectorRichard E. Waldo · Plymouth, MAExec · DirectorBrent Segal · Plymouth, MADirectorCatherine C. Baucom · Plymouth, MAExec · DirectorDerek L. Duke · Palm City, FLDirectorChristopher J. Price · White Plains, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗